Cargando…

Post-vaccination T cell immunity to omicron

In late 2021, the omicron variant of SARS Coronavirus 2 (SARS-CoV-2) emerged and replaced the previously dominant delta strain. Effectiveness of COVID-19 vaccines against omicron has been challenging to estimate in clinical studies or is not available for all vaccines or populations of interest. T c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jacobsen, Henning, Cobos Jiménez, Viviana, Sitaras, Ioannis, Bar-Zeev, Naor, Čičin-Šain, Luka, Higdon, Melissa M., Deloria-Knoll, Maria
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9386871/ https://www.ncbi.nlm.nih.gov/pubmed/35990661 http://dx.doi.org/10.3389/fimmu.2022.944713

Ejemplares similares

Post-Vaccination Neutralization Responses to Omicron Sub-Variants
por: Jacobsen, Henning, et al.
Publicado: (2022)

Systematic review of primary and booster COVID-19 sera neutralizing ability against SARS-CoV-2 omicron variant
por: Sitaras, Ioannis, et al.
Publicado: (2022)

Systematic review and meta-analysis of the factors affecting waning of post-vaccination neutralizing antibody responses against SARS-CoV-2
por: Jacobsen, Henning, et al.
Publicado: (2023)

Assessing the Reliability of SARS-CoV-2 Neutralization Studies That Use Post-Vaccination Sera
por: Jacobsen, Henning, et al.
Publicado: (2022)

Systematical assessment of the impact of single spike mutations of SARS-CoV-2 Omicron sub-variants on the neutralization capacity of post-vaccination sera
por: Katzmarzyk, Maeva, et al.
Publicado: (2023)

Duration of effectiveness of vaccination against COVID-19 caused by the omicron variant
por: Higdon, Melissa M, et al.
Publicado: (2022)

Assessing COVID-19 vaccine effectiveness against Omicron subvariants: Report from a meeting of the World Health Organization
por: Feikin, Daniel R., et al.
Publicado: (2023)

TMPRSS2 Is Essential for SARS-CoV-2 Beta and Omicron Infection
por: Metzdorf, Kristin, et al.
Publicado: (2023)

Vaccine Vectors Harnessing the Power of Cytomegaloviruses
por: Ynga-Durand, Mario Alberto, et al.
Publicado: (2019)

Expecting the unexpected with COVID-19 vaccines
por: Bar-Zeev, Naor, et al.
Publicado: (2021)

COVID-19 vaccines: early success and remaining challenges
por: Bar-Zeev, Naor, et al.
Publicado: (2020)

Human papillomavirus vaccination strategies for accelerating action towards cervical cancer elimination
por: Shet, Anita, et al.
Publicado: (2023)

Encouraging results from phase 1/2 COVID-19 vaccine trials
por: Bar-Zeev, Naor, et al.
Publicado: (2020)

Welcome evidence of vaccine impact in the Pacific
por: Saketa, Salanieta T, et al.
Publicado: (2020)

Long-term immune protection against SARS-CoV-2 escape variants upon a single vaccination with murine cytomegalovirus expressing the spike protein
por: Kim, Yeonsu, et al.
Publicado: (2022)

The viral context instructs the redundancy of costimulatory pathways in driving CD8(+) T cell expansion
por: Welten, Suzanne PM, et al.
Publicado: (2015)

Omicron Booster in Ancestral Strain Vaccinated Mice Augments Protective Immunities Against Both Delta and Omicron Variants
por: Jia, Liqiu, et al.
Publicado: (2022)

SARS-CoV-2 Omicron (B.1.1.529) Variant: Corticosteroids Treatment/Respiratory Coinfection
por: Elkoshi, Zeev
Publicado: (2022)

Measuring indirect effects of rotavirus vaccine in low income countries
por: Bennett, Aisleen, et al.
Publicado: (2016)

Neutralizing Potency of Prototype and Omicron RBD mRNA Vaccines Against Omicron Variant
por: Zang, Jinkai, et al.
Publicado: (2022)

The importance of booster vaccination in the context of Omicron wave
por: Wei, Zichun, et al.
Publicado: (2022)

The Contribution of Cytomegalovirus Infection to Immune Senescence Is Set by the Infectious Dose
por: Redeker, Anke, et al.
Publicado: (2018)

A Novel Triple-Fluorescent HCMV Strain Reveals Gene Expression Dynamics and Anti-Herpesviral Drug Mechanisms
por: Rand, Ulfert, et al.
Publicado: (2021)

Foscarnet-Type Inorganic-Organic Hybrid Nanoparticles for Effective Antiviral Therapy
por: Khorenko, Mikhail, et al.
Publicado: (2022)

Population science with individual-level data make for better policies
por: Bar-Zeev, Naor, et al.
Publicado: (2021)

Pragmatic trials to inform policy decisions and planning
por: Bar-Zeev, Naor, et al.
Publicado: (2023)

Duration of immunity to SARS-CoV-2 in children after natural infection or vaccination in the omicron and pre-omicron era: A systematic review of clinical and immunological studies
por: Buonsenso, Danilo, et al.
Publicado: (2023)

Reduced binding activity of vaccine serum to omicron receptor-binding domain
por: Li, Mingzhi, et al.
Publicado: (2022)

Neutralizing antibody titers to Omicron six months after vaccination with BNT162b2 in Colombia
por: Zapata-Cardona, María I., et al.
Publicado: (2022)

Prior Vaccination Exceeds Prior Infection in Eliciting Innate and Humoral Immune Responses in Omicron Infected Outpatients
por: Lee, Hye Kyung, et al.
Publicado: (2022)

Omicron infection-associated T- and B-cell immunity in antigen-naive and triple-COVID-19-vaccinated individuals
por: Barros-Martins, Joana, et al.
Publicado: (2023)

Immunity against Delta and Omicron variants elicited by homologous inactivated vaccine booster in kidney transplant recipients
por: Zhang, Lei, et al.
Publicado: (2023)

Cost-effectiveness analysis for rotavirus vaccine decision-making: How can we best inform evolving and complex choices in vaccine product selection?
por: Pecenka, Clint, et al.
Publicado: (2020)

Oxford–AstraZeneca COVID-19 vaccine efficacy
por: Knoll, Maria Deloria, et al.
Publicado: (2021)

Diminished neutralization responses towards SARS-CoV-2 Omicron VoC after mRNA or vector-based COVID-19 vaccinations
por: Jacobsen, Henning, et al.
Publicado: (2022)

Re-evaluating the cost and cost-effectiveness of rotavirus vaccination in Bangladesh, Ghana, and Malawi: A comparison of three rotavirus vaccines
por: Pecenka, Clint, et al.
Publicado: (2018)

Sex Differences in Immunity to Viral Infections
por: Jacobsen, Henning, et al.
Publicado: (2021)

Integrated coastal and ocean management : concepts and practices
por: Cicin-Sain, Biliana
Publicado: (1998)

SARS-CoV-2 Omicron variants: burden of disease, impact on vaccine effectiveness and need for variant-adapted vaccines
por: Pather, Shanti, et al.
Publicado: (2023)

Breakthrough infections with the omicron and delta variants of SARS-CoV-2 result in similar re-activation of vaccine-induced immunity
por: Søraas, Arne, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_snb0ug8395aal78rukoadko3m8